{"id":57666,"name":"DR. EMIL KAKKIS","slug":"dr-emil-kakkis","state":"CA","country":"United States of America","description":"CEO of biotechnology company focusing on rare diseases.","totalSpending":100000,"filings":4,"yearlySpending":[{"year":2023,"income":50000},{"year":2024,"income":50000}],"issues":[{"code":"HCR","display":"Health Issues"}],"firms":["WILLIAMS AND JENSEN, PLLC"],"lobbyists":["LAURA SIMMONS","KURT SCHRADER","KARINA LYNCH","JEANNE HAGGERTY","SUSAN HIRSCHMANN","ALEC ARAMANDA"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["FDA drug approval process for rare diseases, including increased use of biomarkers in the Accelerated Approval Pathway, clinical trial design and other barriers to approval.","FDA regulatory review and approval issues.","FDA regulatory review and approval issues."]}